Cash & equivalents decreased 27.7%
Cash & equivalents changed -27.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -27.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed -37.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Trade receivables changed +22.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed -20.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed -406.1% from the comparable as-filed period.
Gross margin changed -296 basis points from the comparable as-filed period.
Operating cash flow changed -527.5% from the comparable as-filed period.
Operating margin changed +220 basis points from the comparable as-filed period.
Net income changed -29.7% from the comparable as-filed period.
Revenue changed +20.6% from the comparable as-filed period.
Current liabilities changed +15.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating income changed -12.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Research & development changed +22.5% from the comparable as-filed period.
Stock-based compensation changed +24.7% from the comparable as-filed period.
Working capital / assets changed -810 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capital expenditure changed -73.5% from the comparable as-filed period.
Gross profit changed +15.8% from the comparable as-filed period.
SBC / revenue changed +104 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed -181 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current assets changed -8.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Free-cash-flow margin changed -173 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capex / revenue changed -9 basis points from the comparable as-filed period.
Receivables / revenue changed +126 basis points from the comparable as-filed period.
R&D / revenue changed +52 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Total assets changed +1.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capex / revenue changed +9 basis points from the comparable as-filed period.
Stock-based compensation changed +9.1% from the comparable as-filed period.
Operating income changed +8.9% from the comparable as-filed period.
Gross profit changed +15.2% from the comparable as-filed period.
Cash & equivalents changed -18.8% from the comparable as-filed period.
Revenue changed +20.8% from the comparable as-filed period.
Research & development changed +32.5% from the comparable as-filed period.
Operating margin changed +938 basis points from the comparable as-filed period.
Operating cash flow changed -26.4% from the comparable as-filed period. The change ranks at the 17th percentile of 6 prior comparable changes.
Net income changed +63.4% from the comparable as-filed period.
Gross margin changed -350 basis points from the comparable as-filed period.
Free-cash-flow proxy changed -27.0% from the comparable as-filed period. The change ranks at the 17th percentile of 6 prior comparable changes.
Capital expenditure changed +190.4% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.